Replies to post #10867 on GTC Biotherapeutics (fka GTCB)

[OKY]

In my humble opinion a RS does nothing to raise capitol.

I think if there is no partnering that’s the end of GTB
as GTB. They may open again under a new name and
perhaps, if they are honest enough, it will be a buyout
and not a steal.

No more dilution, there isn't enough left in the company.

I think its partnering or buyout or bankruptcy. IMHO

[DragonBits]

I have never seen it where the stock didn't drop after a RS, even when the RS was eventually a very good thing and the stock eventually went much higher.